North America is expected to witness lucrative growth in the ureteral stents market, owing to presence of key players such as Becton, Dickinson and Company (Bard Medical), Cook Medical, and Teleflex Incorporated. Moreover, rising prevalence of kidney disorders in the region is also expected to contribute to the North America ureteral stents market growth. For instance, in November 2018, the National Health and Nutrition Examination Survey (NHANES) published their data regarding prevalence of kidney stone cases in the U.S. According to the 2013–2014 NHANES data, the prevalence of kidney stone in the U.S. was accounted for 10.1%.
Asia Pacific is also expected to show noteworthy market share in ureteral stents market owing to increasing approvals for ureteral stents from healthcare regulatory authorities in the region. For instance, in May 2018, Allium Medical received regulatory clearance from the China Food and Drug Administration (CFDA) to market its portfolio of urological systems that includes products such as minimally-invasive BPH implant and premium urological stents, in China.
Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/2172
The Europe market is also expected to witness significant growth owing to increasing presence of key players in the region. For instance, major players such as Teleflex Incorporated offer a wide range of ureteral stents such as superglide ureteral stents, antireflux valve DD stents, special ureteral stents which include integral stents with one pigtail, and integral stents closed with tips on both sides among others.
Key players operating in the Ureteral Stents Market include HydrUStent, LDA, UROMED Kurt Drews KG, Taewoong Medical Co., Ltd., Pnn Medical A/S, Optimed Medizinische Instrumente GmbH, Applied Medical Resources Corporation, Allium Medical Solutions Ltd., Cook Group, Becton, Dickinson And Company, B. Braun Melsungen AG, Coloplast A/S, Q Urological Corporation, Boston Scientific Corporation, Olympus Corporation, and Teleflex Incorporated.
Increasing prevalence of urological and kidney related disorders is expected to result in a high demand for ureteral stents over the forecast period. For instance, according to the study published by the National Center for Biotechnology Information (NCBI), in October 2018, an estimated 1 to 19% of the population in India is suffering from urolithiasis.
Furthermore, increasing demand for kidney transplant procedures is expected to be another factor contributing to the market growth. For instance, according to the Global Observatory on Donation and Transplantation, 2016, around 89,823 kidney transplant surgeries were performed worldwide in 2016, which was an increase by 6.5% from 2015.
Increasing number of product developments and focus on product improvement are contributing significantly to the growth of the global ureteral stents market. For instance, in 2015, Coloplast A/S conducted a study on its Double Loop Ureteral stent endoscopic placement for Kidney Calculi indication in Europe. Through this study, the company focused on understanding the effects of a silicone hydro-coated double loop ureteral stent on symptoms and quality of life in patients undergoing ureteroscopy for kidney stone.
Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2172